Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Champions Oncology, Inc. - Common Stock (NQ:CSBR)

6.730 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Champions Oncology, Inc. - Common Stock

< Previous 1 2 3 4 Next >
Champions Oncology and Medicines Discovery Catapult Forge Partnership to Accelerate Radiopharmaceutical Therapeutics Development
Via ACCESSWIRE
Champions Oncology: Q3 Earnings Insights
 
Via Benzinga
Champions Oncology Reports Quarterly Revenue of $12.0 Million
Via ACCESSWIRE
Earnings Outlook For Champions Oncology
 
Via Benzinga
Champions Oncology's US Laboratory has Acquired Distinguished CAP Accreditation
Via ACCESSWIRE
Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 12, 2024
Via ACCESSWIRE
Recap: Champions Oncology Q2 Earnings
 
Via Benzinga
Earnings Outlook For Champions Oncology
 
Via Benzinga
Champions Oncology Earnings Perspective: Return On Capital Employed
 
Via Benzinga
Champions Oncology Reports Quarterly Revenue of $13.1 Million
Via ACCESSWIRE
Earnings Scheduled For March 12, 2024
Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for its fourth quarter. 
Via Benzinga
Insiders Buying Solid Biosciences And 2 Other Stocks
Although U.S. stocks closed mixed on Friday, there were a few notable insider trades. 
Via Benzinga
Champions Oncology's Earnings: A Preview
 
Via Benzinga
Insiders Buying Tilly's And 2 Other Stocks
Although U.S. stocks closed mixed on Tuesday, there were a few notable insider trades. 
Via Benzinga
Why Is RiskOn International (ROI) Stock Up 28% Today?
RiskOn International stock is rising higher on Wednesday as investors react to insider buying of ROI shares by Milton C. Ault III. 
Via InvestorPlace
CSBR Stock Earnings: Champions Oncology Beats EPS, Misses Revenue for Q2 2024
CSBR stock results show that Champions Oncology beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
Champions Oncology Reports Quarterly Revenue of $11.6 Million
Via ACCESSWIRE
Earnings Scheduled For December 12, 2023
Companies Reporting Before The Bell • CSP (NASDAQ:CSPI) is likely to report earnings for its fourth quarter. 
Via Benzinga
Johnson Controls, Oracle And 3 Stocks To Watch Heading Into Tuesday
With U.S. stock futures trading higher this morning on Tuesday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Investor Optimism Improves Further Ahead Of Inflation Data; Dow Gains For Third Straight Day
The CNN Money Fear and Greed index showed further improvement in overall market sentiment, while the index remained in the "Greed" zone on Monday. U.S. stocks closed higher on Monday, with the Dow... 
Via Benzinga
Topics Economy Stocks
Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 12, 2023
Via ACCESSWIRE
Champions Oncology's European Research Operations Site Receives ISO-9001:2015 Accreditation and ATS Certification
Via ACCESSWIRE
Champions Oncology Announces the Addition of Brady Davis as President
Via ACCESSWIRE
Champions Oncology Reports Quarterly Revenue of $12.6 Million
Via ACCESSWIRE
Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 13, 2023
Via ACCESSWIRE
Champions Oncology Aannounces Remarkable Lineup of Speakers at Its Translational Oncology Symposium in Boston in September 2023
Via ACCESSWIRE
Champions Oncology Announces a Multi-Year Agreement and Strategic Collaboration with BioVolume to Transform Reproducibility in Preclinical Oncology Efficacy Studies
Via ACCESSWIRE
Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Monday, July 24, 2023
Via ACCESSWIRE
Champions Oncology Announces the Formation of Corellia AI, a Wholly Owned Biotech that Leverages Unique AI-Enabled Workflows for Novel Therapeutic Development
Via ACCESSWIRE
Champions Oncology Announces $5M Stock Repurchase Program
Via ACCESSWIRE
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.